Gloria Shining Huang

17PUBLICATIONS
61CO-AUTHORS
Predictive and prognostic markersCancer geneticsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Molecular evolution
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 13, 2024
ARID1A in Gynecologic Precancers and Cancers.

Jaida E Morgan, Nishah Jaferi, Zainab Shonibare

|Apr 16, 2024
Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.

Stefania Bellone, Kyungjo Jeong, Mari Kyllesø Halle

|Apr 09, 2024
Randomized Phase II Trial of Imiquimod with or without 9-Valent HPV Vaccine versus Observation in Patients with High-grade Pre-neoplastic Cervical Lesions (NCT02864147).

Sangini S Sheth, Ji Eun Oh, Stefania Bellone

|Mar 04, 2024
Correction: Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer.

Dana M Roque, Eric R Siegel, Natalia Buza

|Sep 07, 2023
In Vivo and In Vitro Efficacy of Trastuzumab Deruxtecan in Uterine Serous Carcinoma.

Levent Mutlu, Diego D Manavella, Stefania Bellone

|Jan 03, 2023
What role does adjuvant therapy play in the management of endometrial cancer?

Gloria Shining Huang, Joan Tymon-Rosario, Alessandro D Santin

Pageof 3

Frequent Collaborators

11 joint publications

Alessandro Santin

6 joint publications

Natalia Buza

5 joint publications

Vaagn Andikyan

5 joint publications

Peter E Schwartz